Gamida Cell
Israel - Kiryat GatBiotechnology
Focus: Gamida Cell is an Israeli stem cell therapy biotech specializing in cell and gene therapies for hematologic malignancies and blood disorders. The company operates at pre-commercial stage with a focused pipeline in regenerative medicine.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Gamida Cell
AI assessmentNot HiringNo open roles listed right now. Follow Gamida Cell to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
NiCord®/CordIn™
Patients Transplanted With NiCord/CordIn (Omidubicel)Clinical Trials (1)
NCT02039557Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients
N/AHelp build intelligence for Gamida Cell
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.